Marksans Pharma soars as UK MHRA finds no critical observations at Goa unit

The stock surged 20% to Rs 48.70 on the BSE in intra-day trade on back of heavy volumes.

Marksan Pharma surged 20% to Rs 49 on the BSE in intra-day trade after the company said UK health regulator has completed the inspection of Goa unit without any critical observations.

“The Company's plant located at L-82 & L-83, Verna Industrial Estate, Verna, Goa - 403 722 has had an inspection by UK Medicines and Healthcare products Regulatory Agency (MHRA) from February 14, 2017 to February 17, 2017,” Marksans Pharma said in a exchanges filing.

The same has been completed without any critical observations, it added.

The company said it is awaiting further instructions from the agency